Covered recipient · General Payments record
SEBASTIAN REESE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$319.43
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $300.36 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $124.99 | 1 |
| Lilly USA, LLC | $52.21 | 2 |
| Otsuka America Pharmaceutical, Inc. | $47.35 | 2 |
| Neurocrine BioSciences, Inc. | $40.10 | 2 |
| Teva Pharmaceuticals USA, Inc. | $35.71 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Eisai Inc. | $124.99 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110820771 | CMS |
| Lilly USA, LLC | $26.23 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135944748 | CMS |
| Lilly USA, LLC | $25.98 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135863585 | CMS |
| Neurocrine Biosciences, Inc. | $17.40 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150992820 | CMS |
| Neurocrine Biosciences, Inc. | $22.70 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150965441 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.13 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119169532 | CMS |
| Otsuka America Pharmaceutical, Inc. | $27.22 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119169534 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.78 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151506706 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.93 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151506738 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.